Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Cottone

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 30, 2019
Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignanciesKathrin Sommer, Francesco Cottone, Neil K Aaronson, et al.
BMJ Supportive & Palliative Care|July 19, 2020
Acute promyelocytic leukaemia long-term survivors: higher fatigue and greater overall symptom burdenKathrin Sommer, Marco Vignetti, Francesco Cottone, et al.
Journal of Clinical Epidemiology|March 23, 2021
The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3LEva M Gamper, Francesco Cottone, Kathrin Sommer, et al.
Journal of Clinical Epidemiology|June 21, 2020
Time to health-related quality of life improvement analysis was developed to enhance evaluation of modern anticancer therapiesFrancesco Cottone, Gary S Collins, Amelie Anota, et al.
BMJ Supportive & Palliative Care|November 14, 2019
Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic reviewFrancesco Sparano, Neil K Aaronson, Mirjam A G Sprangers, et al.
Cancer Medicine|December 19, 2022
Raising the standards of patient-centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT projectFabio Efficace, Karin Koinig, Francesco Cottone, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic MalignanciesFabio Efficace, Francesco Cottone, Kathrin Sommer, et al.
The Lancet. Oncology|May 2, 2024
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trialTanja Fehm, Francesco Cottone, Kyle Dunton, et al.
International Journal of Hematology|June 27, 2020
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severityGiovanni Caocci, Marco Vignetti, Andrea Patriarca, et al.
Leukemia|December 22, 2018
Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemiaFabio Efficace, Massimo Breccia, Giuseppe Avvisati, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 30, 2019
Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignanciesKathrin Sommer, Francesco Cottone, Neil K Aaronson, et al.
BMJ Supportive & Palliative Care|July 19, 2020
Acute promyelocytic leukaemia long-term survivors: higher fatigue and greater overall symptom burdenKathrin Sommer, Marco Vignetti, Francesco Cottone, et al.
Journal of Clinical Epidemiology|March 23, 2021
The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3LEva M Gamper, Francesco Cottone, Kathrin Sommer, et al.
Journal of Clinical Epidemiology|June 21, 2020
Time to health-related quality of life improvement analysis was developed to enhance evaluation of modern anticancer therapiesFrancesco Cottone, Gary S Collins, Amelie Anota, et al.
BMJ Supportive & Palliative Care|November 14, 2019
Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic reviewFrancesco Sparano, Neil K Aaronson, Mirjam A G Sprangers, et al.
Cancer Medicine|December 19, 2022
Raising the standards of patient-centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT projectFabio Efficace, Karin Koinig, Francesco Cottone, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic MalignanciesFabio Efficace, Francesco Cottone, Kathrin Sommer, et al.
The Lancet. Oncology|May 2, 2024
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trialTanja Fehm, Francesco Cottone, Kyle Dunton, et al.
International Journal of Hematology|June 27, 2020
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severityGiovanni Caocci, Marco Vignetti, Andrea Patriarca, et al.
Leukemia|December 22, 2018
Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemiaFabio Efficace, Massimo Breccia, Giuseppe Avvisati, et al.
Pageof 7